Table 1.
Analysis population patient characteristics by age strata at cART initiation.
| Age strata | |||
|---|---|---|---|
| Age at cART initiation | <35 | 35–50 | >50 |
| Years, Mean (IQR) | 30(28–33) | 42(38–46) | 56(52–58) |
| N=241 | N=483 | N=168 | |
| Sex | N (%) | N (%) | N (%) |
| Female | 23 (10) | 23 (5) | 4 (2) |
| Male | 218 (90) | 460 (95) | 164 (98) |
| HIV Exposure Transmission | |||
| Heterosexual | 36 (15) | 45 (9) | 17 (10) |
| Intravenous drug use | 18 (7) | 19 (4) | 2 (1) |
| Other/Unknown | 23 (10) | 41 (8) | 23 (14) |
| Men who have sex with men | 164 (68) | 378 (78) | 126 (75) |
| HBV surface antigen at 5 years of cART | |||
| Yes | 12 (5) | 17 (4) | 2 (1) |
| No/Not tested | 229 (95) | 466 (96) | 166 (99) |
| HCV antibody at 5 years of cART | |||
| Yes | 18 (7) | 33 (7) | 4 (2) |
| No/not tested | 223 (93) | 450 (93) | 164 (98) |
| Prior cART HIV RNA plasma viral load (copies/ml) | |||
| 0–400 | 14 (6) | 34 (7) | 17 (10) |
| 400–104 | 22 (9) | 58 (12) | 15 (9) |
| 104–105 | 73 (30) | 124 (26) | 42 (25) |
| >105 | 70 (29) | 161 (33) | 48 (29) |
| Missing | 62 (26) | 106 (22) | 46 (27) |
| CD4 cell count (cells/μL) at cART initiation | |||
| 0–249 | 70 (29) | 176 (36) | 60 (36) |
| 250–499 | 93 (39) | 155 (32) | 64 (38) |
| 500–749 | 33 (14) | 66 (14) | 14 (8) |
| >750 | 11 (5) | 29 (6) | 8 (5) |
| Missing | 34 (14) | 57 (12) | 22 (13) |
| CD4 cell count (cells/μL) at 5 years of cART | |||
| 0–249 | 19 (8) | 30 (6) | 23 (14) |
| 250–499 | 61 (25) | 156 (32) | 49 (29) |
| 500–749 | 84 (35) | 172 (36) | 61 (36) |
| >750 | 77 (32) | 125 (26) | 35 (21) |
| AIDS prior to cART | |||
| Yes | 42 (17) | 96 (20) | 37 (22) |
| No | 199 (83) | 387 (80) | 131 (78) |
| Mono/Duo ARV usage prior to cART | |||
| Yes | 87 (36) | 206 (43) | 70 (42) |
| No | 154 (64) | 277 (57) | 98 (58) |
| Year of cART initiation | |||
| 1996–1999 | 187 (78) | 360 (75) | 121 (72) |
| 2000–2004 | 54 (22) | 123 (25) | 47 (28) |
| Follow-up time after cART initiation | |||
| median (IQR) years | 11.5 (9–13) | 11.5 (9–13) | 11.5 (9–13) |
| Number of CD4 measurements contributed after 5 years of cART | |||
| median (IQR) | 20 (12–27) | 20 (13–28) | 22 (14.5–31.5) |